{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:52:21Z","timestamp":1784821941602,"version":"3.55.0"},"reference-count":121,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"DOI":"10.2146\/ajhp110271","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T19:19:08Z","timestamp":1334776748000},"page":"757-766","source":"Crossref","is-referenced-by-count":36,"title":["Schizophrenia and the immune system: Pathophysiology, prevention, and treatment"],"prefix":"10.1093","volume":"69","author":[{"given":"Michelle D.","family":"Richard","sequence":"first","affiliation":[{"name":"Salem Veterans Affairs Medical Center, Salem, VA; at the time of writing, she was Pharm.D. Candidate, College of Pharmacy, University of Oklahoma, Tulsa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy C.","family":"Brahm","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, Department of Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041203531892300_b1-0690757","unstructured":"National Institute of Mental Health. What is schizophrenia?www.nimh.nih.gov\/health\/publications\/schizophrenia\/what-is-schizophrenia.shtml (accessed 2011 Jul 20)."},{"key":"2019041203531892300_b2-0690757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b3-0690757","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b4-0690757","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0447.2007.01095.x","article-title":"Physical illness and schizophrenia: a review of the literature","volume":"116","author":"Leucht","year":"2007","journal-title":"Acta Psychiatr Scand."},{"key":"2019041203531892300_b5-0690757","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(03)00017-3","article-title":"Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level","volume":"66","author":"Gorwood","year":"2004","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b6-0690757","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0920-9964(96)82950-1","article-title":"Autoimmune diseases in the pedigrees of schizophrenic and control subjects","volume":"20","author":"Wright","year":"1996","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b7-0690757","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/ps.2007.58.9.1165","article-title":"Understanding associations between serious mental illness and HIV among patients in the VA health system","volume":"58","author":"Himelhoch","year":"2007","journal-title":"Psychiatr Serv."},{"key":"2019041203531892300_b8-0690757","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/14737175.9.1.47","article-title":"Treatment of schizophrenia in the 21st century: beyond the neurotransmitter hypothesis","volume":"9","author":"Rogers","year":"2009","journal-title":"Expert Rev Neurother."},{"key":"2019041203531892300_b9-0690757","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch Gen Psychiatry."},{"key":"2019041203531892300_b10-0690757","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.med.58.060904.084114","article-title":"Schizophrenia: new pathological insights and therapies","volume":"58","author":"Jarskog","year":"2007","journal-title":"Annu Rev Med."},{"key":"2019041203531892300_b11-0690757","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtbi.2009.03.024","article-title":"A multi-etiology model of systemic degeneration in schizophrenia","volume":"259","author":"R\u0103dulescu","year":"2009","journal-title":"J Theor Biol."},{"key":"2019041203531892300_b12-0690757","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","article-title":"A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia","volume":"30","author":"Vuillermot","year":"2010","journal-title":"J Neurosci."},{"key":"2019041203531892300_b13-0690757","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.schres.2008.07.020","article-title":"Schizophrenia, \u201cjust the facts\u201d: what we know in 2008. Part 3: neurobiology","volume":"106","author":"Keshavan","year":"2008","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b14-0690757","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","article-title":"Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies","volume":"188","author":"Steen","year":"2006","journal-title":"Br J Psychiatry."},{"key":"2019041203531892300_b15-0690757","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/CMR.8.1.131","article-title":"Viruses, schizophrenia, and bipolar disorder","volume":"8","author":"Yolken","year":"1995","journal-title":"Clin Microbiol Rev."},{"key":"2019041203531892300_b16-0690757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \u201cjust the facts\u201d: what we know in 2008. 2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b17-0690757","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/schbul\/sbp161","article-title":"Association of increased prenatal estrogen with risk factors for schizophrenia","volume":"37","author":"Brown","year":"2011","journal-title":"Schizophr Bull."},{"key":"2019041203531892300_b18-0690757","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med."},{"key":"2019041203531892300_b19-0690757","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbn121","article-title":"Association between prenatal exposure to bacterial infection and risk of schizophrenia","volume":"35","author":"S\u00f8rensen","year":"2009","journal-title":"Schizophr Bull."},{"key":"2019041203531892300_b20-0690757","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.2007.07050740","article-title":"Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects","volume":"165","author":"Dalman","year":"2008","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b21-0690757","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mehy.2006.11.023","article-title":"Parvovirus B19 infection of brain: possible role of gender in determining mental illness and autoimmune thyroid disorders","volume":"69","author":"Hammond","year":"2007","journal-title":"Med Hypotheses."},{"key":"2019041203531892300_b22-0690757","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.psc.2007.04.007","article-title":"Epidemiology of schizophrenia: review of findings and myths","volume":"30","author":"Messias","year":"2007","journal-title":"Psychiatr Clin North Am."},{"key":"2019041203531892300_b23-0690757","volume-title":"The immune system. Chaps. 1 and 3","author":"Parham","year":"2005","edition":"2nd ed"},{"key":"2019041203531892300_b24-0690757","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1592\/phco.28.6.730","article-title":"The case for autoimmunity in the etiology of schizophrenia","volume":"28","author":"Goldsmith","year":"2008","journal-title":"Pharmacotherapy."},{"key":"2019041203531892300_b25-0690757","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","article-title":"Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited","volume":"27","author":"Strous","year":"2006","journal-title":"J Autoimmun."},{"key":"2019041203531892300_b26-0690757","first-page":"1417","article-title":"Function and evaluation of the immune system","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"Hall","year":"2008","edition":"7th ed"},{"key":"2019041203531892300_b27-0690757","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/1744666X.1.1.103","article-title":"Is there an immunologic basis for schizophrenia?","volume":"1","author":"Leonard","year":"2005","journal-title":"Expert Rev Clin Immunol."},{"key":"2019041203531892300_b28-0690757","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/schbul\/sbp147","article-title":"Schizophrenia and 1957 pandemic of influenza: meta-analysis","volume":"36","author":"Selten","year":"2010","journal-title":"Schizophr Bull."},{"key":"2019041203531892300_b29-0690757","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b30-0690757","first-page":"RA71","article-title":"Schizophrenia and viral infection during neurodevelopment: a pathogenesis model?","volume":"14","author":"Fruntes","year":"2008","journal-title":"Med Sci Monit"},{"key":"2019041203531892300_b31-0690757","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia","volume":"61","author":"Brown","year":"2004","journal-title":"Arch Gen Psychiatry."},{"key":"2019041203531892300_b32-0690757","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/ajp.2006.163.5.927","article-title":"Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia","volume":"163","author":"Babulas","year":"2006","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b33-0690757","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b34-0690757","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ajp.162.4.767","article-title":"Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring","volume":"162","author":"Brown","year":"2005","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b35-0690757","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.biopsych.2006.05.024","article-title":"Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth","volume":"61","author":"Mortensen","year":"2007","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b36-0690757","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.micinf.2009.07.007","article-title":"Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring","volume":"11","author":"Xiao","year":"2009","journal-title":"Microbes Infect."},{"key":"2019041203531892300_b37-0690757","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.58.11.1032","article-title":"Maternal infections and subsequent psychosis among offspring","volume":"58","author":"Buka","year":"2001","journal-title":"Arch Gen Psychiatry."},{"key":"2019041203531892300_b38-0690757","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1176\/ajp.2006.163.12.2178","article-title":"No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia?","volume":"163","author":"Brown","year":"2006","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b39-0690757","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.biopsych.2007.09.022","article-title":"Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring","volume":"63","author":"Buka","year":"2008","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b40-0690757","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0006-3223(01)01068-X","article-title":"A.E. Bennett Research Award. Pre-natal rubella, premorbid abnormalities, and adult schizophrenia","volume":"49","author":"Brown","year":"2001","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b41-0690757","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ajp.157.3.438","article-title":"Nonaffective psychosis after prenatal exposure to rubella","volume":"157","author":"Brown","year":"2000","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b42-0690757","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02463148","article-title":"Correlation between levels of autoantibodies to nerve growth factor and the clinical features of schizophrenia in children","volume":"30","author":"Klyushnik","year":"2000","journal-title":"Neurosci Behav Physiol."},{"key":"2019041203531892300_b43-0690757","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/157339609787587591","article-title":"Pediatric immune dysfunction and health risks following early-life immune insult","volume":"5","author":"Dietert","year":"2009","journal-title":"Curr Pediatr Rev."},{"key":"2019041203531892300_b44-0690757","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.mehy.2005.06.033","article-title":"The role of HLA-G in cytokine homeostasis during early pregnancy complicated with maternal infections: a novel etiopathological approach to the neurodevelopmental understanding of schizophrenia","volume":"66","author":"Debnath","year":"2006","journal-title":"Med Hypotheses."},{"key":"2019041203531892300_b45-0690757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/00006450-199707000-00001","article-title":"Maternal intra-uterine infection, cytokines, and brain damage in the preterm newborn","volume":"42","author":"Dammann","year":"1997","journal-title":"Pediatr Res."},{"key":"2019041203531892300_b46-0690757","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am J Psychiatry."},{"key":"2019041203531892300_b47-0690757","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1743-422X-2-70","article-title":"Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other \u201cvirus receptor\u201d diseases","volume":"2","author":"Sallie","year":"2005","journal-title":"Virol J."},{"key":"2019041203531892300_b48-0690757","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuron.2009.09.038","article-title":"Breaking boundaries in neural-immune interactions","volume":"64","author":"McAllister","year":"2009","journal-title":"Neuron."},{"key":"2019041203531892300_b49-0690757","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2006.02.003","article-title":"An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives","volume":"84","author":"Nunes","year":"2006","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b50-0690757","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pnpbp.2007.11.019","article-title":"Increased serum levels of CCL11\/eotaxin in schizophrenia","volume":"32","author":"Teixeira","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"2019041203531892300_b51-0690757","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b52-0690757","first-page":"268","article-title":"Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia","volume":"46","author":"Avgustin","year":"2005","journal-title":"Croat Med J."},{"key":"2019041203531892300_b53-0690757","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpsychires.2005.11.007","article-title":"Decreased T cellular immune response in schizophrenic patients","volume":"41","author":"Riedel","year":"2007","journal-title":"J Psychiat Res."},{"key":"2019041203531892300_b54-0690757","volume":"55","year":"2000","journal-title":"Diagnostic and statistical manual of mental disorders"},{"key":"2019041203531892300_b55-0690757","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmed.2006.01.003","article-title":"Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia?","volume":"12","author":"Kipnis","year":"2006","journal-title":"Trends Mol Med."},{"key":"2019041203531892300_b56-0690757","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2010.04.049","article-title":"Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia","volume":"187","author":"Chang","year":"2011","journal-title":"Psychiatry Res."},{"key":"2019041203531892300_b57-0690757","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.psychres.2008.05.011","article-title":"Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication","volume":"169","author":"Halacheva","year":"2009","journal-title":"Psychiatry Res."},{"key":"2019041203531892300_b58-0690757","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2007.08.002","article-title":"Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis","volume":"190","author":"Sokol","year":"2007","journal-title":"J Neuroimmunol."},{"key":"2019041203531892300_b59-0690757","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/15622970410029926","article-title":"Leukocyte elastase and autoantibodies to nerve growth factor in the acute phase of schizophrenia and their relationship to symptomatology","volume":"5","author":"Shcherbakova","year":"2004","journal-title":"World J Biol Psychiatry."},{"key":"2019041203531892300_b60-0690757","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000071828","article-title":"Platelet-associated antibodies mediate protective autoimmune response in schizophrenia","volume":"48","author":"Sinyakov","year":"2003","journal-title":"Neuropsychobiology."},{"key":"2019041203531892300_b61-0690757","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000235801","article-title":"Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients\u2014part I: young subjects","volume":"60","author":"Spivak","year":"2009","journal-title":"Neuropsychobiology."},{"key":"2019041203531892300_b62-0690757","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000235802","article-title":"Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients\u2014part II: adult subjects","volume":"60","author":"Spivak","year":"2009","journal-title":"Neuropsychobiology."},{"key":"2019041203531892300_b63-0690757","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/glia.10312","article-title":"Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients\u2019 sera","volume":"45","author":"Borda","year":"2004","journal-title":"Glia."},{"key":"2019041203531892300_b64-0690757","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(03)00252-2","article-title":"Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders","volume":"141","author":"Tanaka","year":"2003","journal-title":"J Neuroimmunol."},{"key":"2019041203531892300_b65-0690757","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2009.01.023","article-title":"Increased antibodies for the alpha7 subunit of the nicotinic receptor in schizophrenia","volume":"109","author":"Chandley","year":"2009","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b66-0690757","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1358.024","article-title":"Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor","volume":"1062","author":"Gallowitsch-Puerta","year":"2005","journal-title":"Ann N Y Acad Sci."},{"key":"2019041203531892300_b67-0690757","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.psc.2009.12.003","article-title":"The role of genetics in the etiology of schizophrenia","volume":"33","author":"Gejman","year":"2010","journal-title":"Psychiatr Clin North Am."},{"key":"2019041203531892300_b68-0690757","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.biopsych.2010.03.039","article-title":"The potential role of major histocompatibility complex class I in schizophrenia","volume":"68","author":"Handel","year":"2010","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b69-0690757","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00406-005-0603-9","article-title":"IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia","volume":"256","author":"Schwarz","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"2019041203531892300_b70-0690757","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.mp.4001983","article-title":"Converging evidence for a pseudo-autosomal cytokine receptor gene locus in schizophrenia","volume":"12","author":"Lencz","year":"2007","journal-title":"Mol Psychiatry."},{"key":"2019041203531892300_b71-0690757","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.psc.2009.09.003","article-title":"Clinical perspectives on autoimmune processes in schizophrenia","volume":"32","author":"Yum","year":"2009","journal-title":"Psychiatr Clin North Am."},{"key":"2019041203531892300_b72-0690757","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2005.09.013","article-title":"Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients","volume":"50","author":"Ganzinelli","year":"2006","journal-title":"Neuropharmacology."},{"key":"2019041203531892300_b73-0690757","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/156720206776875894","article-title":"Autoantibodies associated with psychiatric disorders","volume":"3","author":"Margutti","year":"2006","journal-title":"Curr Neurovasc Res."},{"key":"2019041203531892300_b74-0690757","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/schbul\/sbp133","article-title":"Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and non-genetic models","volume":"36","author":"Jaaro-Peled","year":"2010","journal-title":"Schizophr Bull."},{"key":"2019041203531892300_b75-0690757","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrn2841","article-title":"22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia","volume":"11","author":"Karayiorgou","year":"2010","journal-title":"Nat Rev Neurosci."},{"key":"2019041203531892300_b76-0690757","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drudis.2009.12.004","article-title":"Use of biomarkers in the discovery of novel anti-schizophrenia drugs","volume":"15","author":"Mikkelsen","year":"2010","journal-title":"Drug Discov Today."},{"key":"2019041203531892300_b77-0690757","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psc.2009.10.001","article-title":"Predictive and diagnostic genetic testing in psychiatry","volume":"33","author":"Mitchell","year":"2010","journal-title":"Psychiatr Clin North Am."},{"key":"2019041203531892300_b78-0690757","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2009.09.036","article-title":"Neuroendocrine and immune influences on the CNS: it\u2019s a matter of sex","volume":"64","author":"Bale","year":"2009","journal-title":"Neuron."},{"key":"2019041203531892300_b79-0690757","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.mp.4001748","article-title":"The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia","volume":"11","author":"Ashdown","year":"2006","journal-title":"Mol Psychiatry."},{"key":"2019041203531892300_b80-0690757","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","article-title":"Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction","volume":"44","author":"Bechter","year":"2010","journal-title":"J Psychiatr Res."},{"key":"2019041203531892300_b81-0690757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archpsyc.1967.01730190003001","article-title":"Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques","volume":"16","author":"Heath","year":"1967","journal-title":"Arch Gen Psychiatry."},{"issue":"(suppl 9)","key":"2019041203531892300_b82-0690757","first-page":"5","article-title":"Risk of cardiovascular disease and sudden death in schizophrenia","volume":"63","author":"Davidson","year":"2002","journal-title":"J Clin Psychiatry."},{"key":"2019041203531892300_b83-0690757","first-page":"5","article-title":"[Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication.]","volume":"19","author":"Baskak","year":"2008","journal-title":"Turk Psikiyatri Derg"},{"key":"2019041203531892300_b84-0690757","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2007.08.044","article-title":"Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders","volume":"267","author":"De Keyser","year":"2008","journal-title":"J Neurol Sci."},{"key":"2019041203531892300_b85-0690757","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neulet.2006.06.051","article-title":"Increased complement classical and mannan-binding lectin pathway activities in schizophrenia","volume":"404","author":"Mayilyan","year":"2006","journal-title":"Neurosci Lett."},{"key":"2019041203531892300_b86-0690757","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/15622970701227803","article-title":"Complement C4B protein in schizophrenia","volume":"9","author":"Mayilyan","year":"2008","journal-title":"World J Biol Psychiatry."},{"key":"2019041203531892300_b87-0690757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.05.005","article-title":"Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients","volume":"47","author":"Singh","year":"2009","journal-title":"Cytokine."},{"key":"2019041203531892300_b88-0690757","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/17520363.2.4.385","article-title":"Problems and promise of immunological factors as biomarkers for schizophrenia","volume":"2","author":"Herberth","year":"2008","journal-title":"Biomarkers Med."},{"key":"2019041203531892300_b89-0690757","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1096\/fj.04-1652fje","article-title":"Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells","volume":"18","author":"Ilani","year":"2004","journal-title":"FASEB J."},{"key":"2019041203531892300_b90-0690757","first-page":"1","article-title":"Infection, inflammation, and mental illness. The body\u2019s immune response to infectious agents may imperil the brain","volume":"26","author":"Bennett","year":"2009","journal-title":"Harv Ment Health Lett."},{"key":"2019041203531892300_b91-0690757","first-page":"9","article-title":"Life event, stress and illness","volume":"15","author":"Salleh Mohd","year":"2008","journal-title":"MJMS."},{"key":"2019041203531892300_b92-0690757","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0006-3223(00)01052-0","article-title":"Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia","volume":"48","author":"Walder","year":"2000","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b93-0690757","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/092986710790979980","article-title":"Progress in COX-2 inhibitors: a journey so far","volume":"17","author":"Chakraborti","year":"2010","journal-title":"Curr Med Chem."},{"key":"2019041203531892300_b94-0690757","first-page":"13","article-title":"An informative case of Graves\u2019 disease with implications for schizophrenia","volume":"53","author":"Adams","year":"2004","journal-title":"J Clin Lab Immunol."},{"key":"2019041203531892300_b95-0690757","first-page":"744","article-title":"PDEs as drug targets for CNS immune disorders","volume":"9","author":"Hebb","year":"2008","journal-title":"Curr Opin Investig Drugs."},{"key":"2019041203531892300_b96-0690757","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bcp.2007.07.015","article-title":"Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men","volume":"74","author":"Olincy","year":"2007","journal-title":"Biochem Pharmacol."},{"key":"2019041203531892300_b97-0690757","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1517\/14728220903188438","article-title":"Histamine H3 and H4 receptors as novel drug targets","volume":"18","author":"Tiligada","year":"2009","journal-title":"Expert Opin Investig Drugs."},{"key":"2019041203531892300_b98-0690757","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b99-0690757","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.mp.4001959","article-title":"Rationale for a trial of immunosuppressive therapy in acute schizophrenia","volume":"12","author":"Knight","year":"2007","journal-title":"Mol Psychiatry."},{"key":"2019041203531892300_b100-0690757","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch Gen Psychiatry."},{"key":"2019041203531892300_b101-0690757","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00023210-200519100-00001","article-title":"COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date","volume":"19","author":"Riedel","year":"2005","journal-title":"CNS Drugs."},{"key":"2019041203531892300_b102-0690757","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1196\/annals.1361.113","article-title":"Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases","volume":"1051","author":"Skurkovich","year":"2005","journal-title":"Ann N Y Acad Sci."},{"key":"2019041203531892300_b103-0690757","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","article-title":"Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia","volume":"65","author":"Zhang","year":"2004","journal-title":"J Clin Psychiatry."},{"key":"2019041203531892300_b104-0690757","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0278-5846(03)00036-8","article-title":"The influence of olanzapine on immune cells in patients with schizophrenia","volume":"27","author":"Bilici","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"2019041203531892300_b105-0690757","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0893-133X(98)00006-2","article-title":"Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients","volume":"19","author":"Hinze-Selch","year":"1998","journal-title":"Neuropsychopharmacology."},{"key":"2019041203531892300_b106-0690757","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","article-title":"Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia","volume":"50","author":"Kowalski","year":"2001","journal-title":"Schizophr Res."},{"key":"2019041203531892300_b107-0690757","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/JCP.0b013e3181a44575","article-title":"Glucocorticosteroids associated with a decreased risk of psychosis","volume":"29","author":"Laan","year":"2009","journal-title":"J Clin Psychopharmacol."},{"key":"2019041203531892300_b108-0690757","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","article-title":"Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine","volume":"89","author":"Maes","year":"1994","journal-title":"Acta Psychiatr Scand."},{"key":"2019041203531892300_b109-0690757","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/schbul\/sbl005","article-title":"Early detection of first-episode psychosis: the effect on 1-year outcome","volume":"32","author":"Larsen","year":"2006","journal-title":"Schizophr Bull."},{"key":"2019041203531892300_b110-0690757","unstructured":"Texas Department of State Health Services. Algorithm for the treatment of schizophrenia. http:\/\/bellsouthpwp2.net\/d\/r\/drcook\/Lane\/TMAP\/TMAP%20Schizophrenia%20Web.pdf (accessed 2011 Jul 11)."},{"key":"2019041203531892300_b111-0690757","unstructured":"American Psychiatric Association. Schizophrenia clinical tools treatment algorithm. www.psychiatryonline.com\/popup.aspx?aID=46264 (accessed 2011 Jul 11)."},{"key":"2019041203531892300_b112-0690757","first-page":"340","article-title":"Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour","volume":"26","author":"Gobbi","year":"2001","journal-title":"J Psychiatry Neurosci."},{"key":"2019041203531892300_b113-0690757","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol Psychiatry."},{"key":"2019041203531892300_b114-0690757","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared with risperidone alone in schizophrenia","volume":"159","author":"M\u00fcller","year":"2002","journal-title":"Am J Psychiatry."},{"issue":"suppl 2","key":"2019041203531892300_b115-0690757","first-page":"ii5","volume":"256","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2019041203531892300_b116-0690757","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S1461145705005808","article-title":"The effects of celecoxib augmentation on cytokine levels in schizophrenia","volume":"9","author":"Bresee","year":"2006","journal-title":"Int J Neuropsychopharmacol."},{"key":"2019041203531892300_b117-0690757","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000119379","article-title":"Side effect profile of azathioprine in the treatment of chronic schizophrenic patients","volume":"36","author":"Levine","year":"1997","journal-title":"Neuropsychobiology."},{"key":"2019041203531892300_b118-0690757","first-page":"HY19","article-title":"Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases","volume":"10","author":"Das","year":"2004","journal-title":"Med Sci Monit"},{"key":"2019041203531892300_b119-0690757","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nut.2010.04.003","article-title":"Influence of polyunsaturated fatty acids and their metabolites on stem cell biology","volume":"27","author":"Das","year":"2011","journal-title":"Nutrition."},{"key":"2019041203531892300_b120-0690757","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch Gen Psychiatry."},{"key":"2019041203531892300_b121-0690757","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol Psychiatry."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/9\/757\/28361041\/ajhp0757.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T23:56:43Z","timestamp":1555113403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/9\/757\/5112204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":121,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110271","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5,1]]},"published":{"date-parts":[[2012,5,1]]}}}